Wall Street Backs the Wrong Biotech

In this video, David Williamson reviews some of his favorite biotech firms. Many analysts have thrown their weight behind Biogen  (NASDAQ: BIIB  ) and its new BG12 drug for multiple sclerosis. However, David favors Gilead  (NASDAQ: GILD  ) over Biogen since Gilead has a larger, more diverse product pipeline. Celgene  (NASDAQ: CELG  ) is the No. 1 biotech in David's opinion since it also has blockbuster drugs but a PEG of less than 1.0. Amgen  (NASDAQ: AMGN  ) is a big company with more products in development than most people realize. Overall, for value and future earnings potential, David likes Celgene the best.

Can Celgene continue to soar?
Every in-the-know biotech investor has an eye on Celgene. Shares have skyrocketed this year as the company outlined a plan to almost triple its profits in only a few years. But should you buy the story Celgene is selling? Make sure you understand the key opportunities and risks facing this company by picking up The Motley Fool's brand-new premium report on Celgene. To claim your copy today, simply click here now.


Read/Post Comments (3) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 14, 2013, at 4:38 PM, RU1986 wrote:

    Spelling Biogen's name correctly might get your opinion a little more consideration.

  • Report this Comment On April 15, 2013, at 8:30 AM, Grayhouse wrote:

    Seriously! Who's the really the "fool"? Anyone that listens to your short backed speech disguised as analysis.

  • Report this Comment On April 15, 2013, at 9:59 AM, XMFSharona wrote:

    @RU1986 & @Grayhouse -- Thanks for the feedback; we've made the fix. Fool on!

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2361982, ~/Articles/ArticleHandler.aspx, 10/21/2014 10:20:37 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 16,473.37 73.70 0.45%
S&P 500 1,922.55 18.54 0.97%
NASD 4,368.38 52.31 1.21%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2014 10:04 AM
BIIB $316.74 Up +5.33 +1.71%
Biogen Idec CAPS Rating: ****
CELG $95.04 Up +3.04 +3.30%
Celgene CAPS Rating: *****
AMGN $138.82 Up +1.31 +0.95%
Amgen, Inc. CAPS Rating: ****
GILD $104.06 Up +1.85 +1.81%
Gilead Sciences CAPS Rating: ****

Advertisement